Geographic Atrophy

Researchers in the United States are advancing a groundbreaking stem-cell retinal implant for people with advanced dry age-related macular degeneration...

Australian researchers have for the first time pinpointed specific genetic changes that increase the risk of severe, sight-threatening forms of...

Australia now has two treatments for geographic atrophy (GA) after the Therapeutic Goods Administration (TGA) approved a second medication. It...

A landmark international clinical trial has demonstrated the potential of a subretinal photovoltaic implant to restore central vision in patients...

Two of Australia’s leading experts in macular research – Professor Robyn Guymer AM and Associate Professor Zhichao Wu from the...

Ultra-widefield optomap retinal imaging has transformed care at Rachel Cauchi Optometrists, where every patient is now screened on the device....

At the completion of this article, the reader should be able to: Manage patient expectations and adherence to treatment, in...

Approval of the first therapy for geographic atrophy (GA), Syfovre (pegcetacoplan), is being hailed a “landmark moment” for the the...

The Therapeutic Goods Administration (TGA) has approved the first treatment for geographic atrophy (GA) in Australia, Syfovre from Apellis Pharmaceuticals,...

Patients diagnosed with late-stage age-related macular degeneration in Australia have entirely different prospects, depending on what form they have. But...